co.don® AG (ISIN: DE 000517360 3) signs an exclusive distribution agreement for Greece
Teltow, January 4, 2007 – co.don® AG (ISIN DE000517360 3), a Tissue Engineering and Regenerative Medicine biopharmaceutical company that develops, manufactures and markets innovative autologous cartilage and bone tissue replacement and repair therapeutics, has signed an exclusive two-year distribution agreement with ARTHROSIS SA, Metamorfosi, near Athens, Greece, - to market co.don chondrosphere®, co.don chondrotransplant® DISC and co.don osteotransplant® DENT in Greece.
With this agreement, co.don® AG continues its strategy to cooperate with regional partners to entry a further important European market.
ARTHROSIS SA is an established distribution company which has been working in the areas of orthopedics and neurosurgery for 11 years. Its main focus is the distribution of arthroscopic and endoscopic devices as well as orthobiologics. The annual sales in 2006 amounted to approx. € 17 million.
The development of the private health sector in Greece shows strong dynamics that can be profitably used by foreign investors as well. Imported goods become more important, compared to domestics goods. In 2004, the sales in the private health sector in Greece rose by 15,6% to almost € 1,2 billion, compared to the previous year. Private companies in the health sector in Greece can benefit from the rapid increase of the life standard in the last 10 - 15 years.
Dr. Olivera J. Alasevic
Founded: +++ 1993 +++
CEO: +++ Dr. Olivera J. Alasevic +++
Facts: +++ 14.02.2001, IPO-Neuer Markt +++ WKN 517 360 +++ CNW
co.don® AG is one of the leading biopharmaceutical companies in the area of Regenerative Medicine/Tissue Engineering. Since 1997, co.don® AG has developed, manufactured and distributed human Tissue engineering therapeutics for the regeneration of articular cartilage, bone and intervertebral discs. The company is headquartered in Teltow, near Berlin, Germany. For more information, please visit www.codon.de
- Contact Information
- Matthias Meißner
- Investor Relations
- co.don® AG
- Contact via E-mail
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.